Amit Gupta - 01 Oct 2026 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CDLX
Reported as of: 01 Oct 2026
Net transaction value: -$46,750
SEC form: 4
Accepted by SEC: 02 Oct 2026, 17:30:46 UTC
Prior SEC filing: 18 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Chris Cheng, Attorney-in-Fact

Key filing fact

Amit Gupta filed Form 4 for Cardlytics, Inc. (CDLX) on 02 Oct 2026.

Key facts

This page summarizes Amit Gupta's Form 4 filing for Cardlytics, Inc. (CDLX).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 02 Oct 2026, 17:30.

Change

Previous filing in this sequence was filed on 18 Aug 2026.
Current net transaction value: -$46,750.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001961238 Primary reporting owner

Gupta Amit

Relationship: Chief Executive Officer, Director
Address: 675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA
Signature: /s/ Chris Cheng, Attorney-in-Fact
Signature date: 02 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDLX transaction

Common Stock

Options Exercise

Transaction value
Shares: +18,750
Change %: +15%
Price
Shares after: 144,139
Date: 01 Oct 2026
Ownership: Direct
Footnotes: F1

CDLX transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,500
Change %: +8.7%
Price
Shares after: 156,639
Date: 01 Oct 2026
Ownership: Direct
Footnotes: F1

CDLX transaction

Common Stock

Sale

Transaction value: $28,051
Shares: -10,351
Change %: -6.6%
Price: $2.71
Shares after: 146,288
Date: 01 Oct 2026
Ownership: Direct
Footnotes: F2

CDLX transaction

Common Stock

Sale

Transaction value: $18,699
Shares: -7,382
Change %: -5%
Price: $2.53
Shares after: 138,906
Date: 02 Oct 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDLX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -18,750
Change %: -14%
Price: $0.000000^*
Shares after: 112,500
Date: 01 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,750
Exercise price
Footnotes: F1, F4

CDLX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -12,500
Change %: -33%
Price: $0.000000^*
Shares after: 25,000
Date: 01 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,500
Exercise price
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Footnote F3

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Footnote F4

The RSUs vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Footnote F5

50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.